Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL15-mediated crosstalk between LSECs and CD8⁺ tissue-resident memory T cells drives alcohol-associated hepatitis.

Hepatology communications·2026
Same author

Gut serotonin regulates Kupffer cell appetite for drug carriers.

Cell research·2026
Same author

Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers.

Nature reviews. Immunology·2026
Same author

Peritoneal macrophages regulate distal wound healing via endocrine release of plasma fibronectin.

The Journal of clinical investigation·2026
Same author

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management.

The lancet. Gastroenterology & hepatology·2026
Same author

Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study.

World journal of hepatology·2026

Related Experiment Video

Updated: May 18, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Sterile inflammation in the liver.

Paul Kubes1, Wajahat Z Mehal2

  • 1Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.

Gastroenterology
|September 18, 2012
PubMed
Summary

Sterile inflammation (SI), triggered by tissue damage rather than pathogens, drives liver diseases like NASH and AFLD. Targeting damage-associated molecular patterns (DAMPs) and their pathways offers new therapeutic strategies for these conditions.

More Related Videos

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver
07:06

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver

Published on: February 6, 2018

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver
07:06

Two-photon Intravital Imaging of Leukocytes During the Immune Response in Lipopolysaccharide-treated Mouse Liver

Published on: February 6, 2018

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

Area of Science:

  • Immunology
  • Pathology
  • Hepatology

Background:

  • Sterile inflammation (SI) occurs without pathogens, driven by tissue stress and injury.
  • SI is a critical factor in drug-induced liver injury, nonalcoholic steatohepatitis (NASH), and alcoholic steatohepatitis (AFLD), contributing to fibrosis and cancer.
  • Endogenous damage-associated molecular patterns (DAMPs) are released during tissue injury, activating immune cells via pattern recognition receptors.

Purpose of the Study:

  • To elucidate the mechanisms of sterile inflammation in liver pathology.
  • To identify therapeutic targets for SI-driven liver diseases.

Main Methods:

  • Review of DAMPs, their receptors, and downstream signaling pathways, including inflammasome activation.
  • Analysis of immune responses triggered by DAMPs, such as cytokine production and immune cell recruitment.
  • Examination of the role of SI in liver disease pathogenesis.

Main Results:

  • Over 20 DAMPs have been identified, activating pattern recognition receptors and initiating inflammatory cascades.
  • DAMPs induce inflammasome assembly, leading to caspase-1 activation and the release of interleukin-1β and other pro-inflammatory cytokines.
  • SI is a significant contributor to liver pathology in developed countries, with limited specific treatments.

Conclusions:

  • DAMPs are key mediators of sterile inflammation and liver disease progression.
  • Understanding DAMPs, their receptors, and signaling pathways provides numerous therapeutic targets.
  • Development of antagonists targeting these pathways holds promise for treating SI-driven liver diseases.